How much funding has Basking Biosciences raised?

Basking Biosciences has raised $94.9M in total funding, most recently a Extension Round.

Who are Basking Biosciences's investors?

Basking Biosciences's investors include ARCH Venture Partners, Rev1 Ventures, RA Capital Management, Yosemite, Sozo Ventures, Insight Partners.

When was Basking Biosciences founded?

Basking Biosciences was founded in 2020.

Where is Basking Biosciences headquartered?

Basking Biosciences is headquartered in Columbus, Ohio, United States.

What industry is Basking Biosciences in?

Basking Biosciences operates in Life Sciences, Biotech, Healthcare.

How many employees does Basking Biosciences have?

Basking Biosciences has 1-10 employees.

Basking Biosciences

Thrombosis Treatment Innovation

Columbus, United States · Founded 2020 · $94.9M raised

Life Sciences

Biotech

Healthcare

Headquarters: Columbus, Ohio
Employees: 1–10
Founded: 2020
Business Model: B2B

Website: baskingbiosciences.com
Total Funding: $94.9M
Last Round: $27.5M Extension RoundOct 2025
Rounds: 5

About

Founded in 2019 and based in Research Triangle Park, NC, Basking Biosciences is a clinical-stage biotech developing the first reversible thrombolytic therapy for acute ischemic stroke. Their lead candidate BB-031 inhibits von Willebrand Factor with a direct-acting reversal agent BB-025, enabling safer intervention in time-critical thrombotic conditions.

Summary

Basking Biosciences is a Life Sciences company based in Columbus, United States, founded in 2020. It has raised $94.9M in total across 5 rounds, most recently a $27.5M Extension Round round in Oct 2025. Investors include ARCH Venture Partners, Rev1 Ventures and RA Capital Management.